Symbol
Nektar Therapeutics
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.55
Current price of the stock
$5M
Trading volume of the stock
$115.5M
Market capitalization of the company
Micro Cap
Category of market capitalization
15.28%
Long-term growth mean estimate
4.11
Mean analyst rating
689.45%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
4.24
Current ratio
81.62%
Gross profit margin
-142.37%
Operating profit margin
-142.37%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-153.57%
Pretax profit margin
-153.61%
Net profit margin
-75.81%
Measures profitability relative to shareholders' equity
-75.81%
ROE excluding intangible assets
-12.03%
Measures profitability relative to total assets
-75.81%
Measures profitability relative to invested capital
0.08
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.66
Measures valuation relative to earnings
-0.78
P/E based on future earnings estimates
1.24
Measures valuation relative to sales
2.08
Measures valuation relative to book value
-0.24
Measures valuation relative to operating cash flow
-0.24
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
